Procain

Procaine

HCID 4914

Grundinformationen

CAS
59-46-1
Standard-SMILES
CCN(CC)CCOC(=O)c1ccc(N)cc1
InChIKey
MFDFERRIHVXMIY-UHFFFAOYSA-N
Summenformel
C13H20N2O2
Durchschnittliche Molmasse
236,31 g/mol
Monoisotopische Masse
236,15247788

Überblick

Procaine is a benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol. It has a role as a central nervous system depressant, a local anaesthetic, a peripheral nervous system drug and a drug allergen. It is a benzoate ester, a substituted aniline and a tertiary amino compound. It is functionally related to a 4-aminobenzoic acid and a 2-diethylaminoethanol. It is a conjugate base of a procaine(1+).

Namen und Bezeichner

Bevorzugter Name
Procaine
IUPAC
2-(diethylamino)ethyl 4-aminobenzoate
Lokaler Name
Procain
Englischer Name
Procaine
Summenformel
C13H20N2O2
Molmasse
236.31

Namen und Synonyme

procaine59-46-12-(Diethylamino)ethyl 4-aminobenzoateSpinocaineProcainVitamin H3DuracaineNissocaineNovocaineProcaine, baseProcainaScurocaine
Weitere Namen anzeigen
PNovocainProcineProcaine powderProcaine hydrochlori2-(Diethylamino)ethyl p-aminobenzoate4-amino-benzoicaci2-(diethylamino)ethylester
Benzoic acid, 4-amino-, 2-(diethylamino)ethyl esterProcainum2-Diethylaminoethyl 4-aminobenzoateDiethylaminoethyl p-aminobenzoate2-Diethylaminoethyl p-aminobenzoatep-Aminobenzoic acid 2-diethylaminoethyl ester4-Aminobenzoic acid diethylaminoethyl esterBenzoic acid, p-amino-, 2-(diethylamino)ethyl ester

Datenbank-Bezeichner

CAS
59-46-1
PubChem CID
4914
DTXSID
DTXSID7045021
ChEMBL
CHEMBL569
ChEBI
CHEBI:8430
UNII
4Z8Y51M438
EC Number
200-426-9
Nikkaji
J4.603E

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,9
Polarare Oberfläche (TPSA)
55,6 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
7
Schwere Atome
17

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2 Einträge

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

SpringerMaterials PropertiesCrystal structure
LogP · 3 Einträge

log Kow= 1.92

1.8

2.1

Color/FormAnhydrous plates, tables from ligroin or ether
Solubility · 5 Einträge

Crystals, mp 153-156 °C, sol in water, alcohol /Nitrate/

Crystals. Six-sided plates, monoclinic or triclinic, mp 153-156 °C. One gram dissolves in 1 ml water and in 30 ml alcohol. Slightly sol in chloroform. Almost insoluble in ether. The pH of a 0.1 M aqueous solution is 6.0. /Hydrochloride/

ODORLESS; AQ SOLN ACID TO LITMUS; PKA 8.7; SMALL WHITE CRYSTALS; 1 G SOL IN 1 ML WATER OR 15 ML ALC; SLIGHTLY SOL IN CHLOROFORM; PRACTICALLY INSOL IN ETHER /HYDROCHLORIDE/

Sol in alcohol, ether, benzene, chloroform

Soluble in ethanol, ethyl ether, and benzene

Physikochemische Eigenschaften

Schmelzpunkt
61 ° · 61°
Siedepunkt
378.78 °C · 378.78°C (rough estimate)
Dichte
1.0604 · 1.0604 (rough estimate)
Brechungsindex
1.543 · 1.5430 (estimate)
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
Löslichkeit
DMSO (Slightly), Methanol (Slightly)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory InformationProcaine: Does not have an individual approval but may be used under an appropriate group standard
Hazards Summary · 1 Eintrag

Allergic contact dermatitis reported in doctors, dentists, and veterinarians; [Kanerva, p. 1829] Procaine allergy used to be a common skin sensitizer for dentists. There exists cross-reactivity between procaine, benzocaine, and tetracaine but not with lidocaine and other amide-type local anesthetics currently used. [Kanerva, p. 434]

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Sicherheit und Schutzausrüstung

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxikologische Informationen

Interactions · 5 Einträge

WELL-KNOWN CLASS OF PROLONGING AGENTS...SKF-525-A...INHIBITS...MICROSOMAL ESTERASE ACTIVITY TOWARDS PROCAINE.

... /PROCAINE/ IS HYDROLYZED IN VIVO TO PRODUCE PARAAMINOBENZOIC ACID, WHICH INHIBITS THE ACTION OF SULFONAMIDES. THUS, LARGE DOSES SHOULD NOT BE ADMINISTERED TO PATIENTS TAKING SULFONAMIDE DRUGS.

PROCAINE IM CAN POTENTIATE PENTOBARBITAL ANESTHESIA... SYMPATHOMIMETICS...& MONOAMINE OXIDASE INHIBITORS MAY HAVE THEIR HYPERTENSIVE EFFECTS POTENTIATED BY PROCAINE. ...MAY POTENTIATE OR BE POTENTIATED BY PHENOTHIAZINE TRANQUILIZERS, CHOLINESTERASE INHIBITORS...& MUSCLE RELAXANTS SUCH AS SUCCINYLCHOLINE.

SUBSTRATE COMPETITION PROBABLY ACCOUNTS FOR INHIBITION OF SUCCINYLCHOLINE HYDROLYSIS BY PROCAINE.

For more Interactions (Complete) data for PROCAINE (17 total), please visit the HSDB record page.

Adverse Effects · 2 Einträge

Skin Sensitizer - An agent that can induce an allergic reaction in the skin.

The adverse effects of procaine administration are similar to those of other aminoester anesthetics. Increased intravascular levels mediate most side effects; this can be due to overdosage, entry into intravascular spaces, and potentiation from reduced metabolism. More rarely, patients may experience adverse effects secondary to hypersensitivity or idiosyncrasy.

Exposure RoutesOral, Infiltration, Intramuscular
Toxicity Summary · 1 Eintrag

Procaine acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Procaine has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex.

Signs and Symptoms · 1 Eintrag

An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); chest pain or slow or irregular heartbeats; dizziness or drowsiness; anxiety or restlessness; nausea or vomiting; trembling, shaking, or seizures (convulsions). Other less serious side effects such as numbness, tingling, or minor pain at or around the injection site are more likely to occur.(L1459)

Human Toxicity Excerpts · 1 Eintrag

IN 2...INSTANCES LOSS OF VISION FOLLOWED INJECTION OF PROCAINE FOR EXTRACTION OF TEETH. IN ONE OF THESE INSTANCES SEVERE VISUAL LOSS WAS NOTED WITHIN DAY FOLLOWING EXTRACTION & THERE WAS NO SUBSEQUENT IMPROVEMENT. ULTIMATELY OPTIC NERVES BECAME ATROPHIC & VISION WAS /SRP: REDUCED TO/ PERCEPTION OF HAND MOVEMENT.

Regulatorische Informationen

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Sicherheitsdaten

ridadr
3249
hs_code
2922.49.3700
RTECS-Nr.
DG2100000
Toxizität
LD50 in mice (mg/kg): 195 i.p.; 45 i.v. (North, Urbach)
hazard_class
6.1(b)
packing_group
III

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 6 Einträge

N01BA02

C - Cardiovascular system

S - Sensory organs

N - Nervous system

QC - Cardiovascular system

QS - Sensory organs

Pharmacodynamics · 1 Eintrag

Procaine is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Procaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Procaine is an ester anesthetic. It is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-aminobenzoic acid (PABA), which is then excreted by the kidneys into the urine.

Mechanism of Action · 6 Einträge

Procaine acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Procaine has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex.

LOCAL ANESTHETICS BLOCK CONDUCTION BY DECREASING OR PREVENTING THE LARGE TRANSIENT INCREASE IN THE PERMEABILITY OF EXCITABLE MEMBRANES TO SODIUM IONS THAT NORMALLY IS PRODUCED BY A SLIGHT DEPOLARIZATION OF THE MEMBRANE. /LOCAL ANESTHETIC/

LOCAL ANESTHETICS BLOCK CONDUCTION IN NERVE PERHAPS BY COMPETING WITH CALCIUM @ SOME SITE THAT CONTROLS PERMEABILITY OF MEMBRANE. ... LOCAL ANESTHETICS ALSO REDUCE PERMEABILITY OF RESTING NERVE TO POTASSIUM AS WELL AS TO SODIUM IONS. /LOCAL ANESTHETICS/

AS THE ANESTHETIC ACTION PROGRESSIVELY DEVELOPS IN A NERVE, THE THRESHOLD FOR ELECTRICAL EXCITABILITY GRADUALLY INCREASES, THE RATE OF RISE OF THE ACTION POTENTIAL DECLINES, IMPULSE CONDUCTION SLOWS, & THE SAFETY FACTOR FOR CONDUCTION DECREASES; THESE FACTORS DECREASE THE PROBABILITY OF PROPAGATION OF THE ACTION POTENTIAL, AND NERVE CONDUCTION FAILS. /LOCAL ANESTHETICS/

POSTSYNAPTIC ACTION ... END-PLATE CURRENT IS MUCH PROLONGED BY PROCAINE. SIMILARLY, WHEN ... ADDED TO FLUID PERFUSING GANGLION, PREGANGLIONIC STIMULATION FAILS TO ELICIT POSTGANGLIONIC DISCHARGES & GANGLION CELLS BECOME INSENSITIVE TO STIMULATION BY ACETYLCHOLINE.

IN ADDITION TO BLOCKING CONDITIONS IN NERVE AXONS IN THE PERIPHERAL NERVOUS SYSTEM, LOCAL ANESTHETICS INTERFERE WITH THE FUNCTION OF ALL ORGANS IN WHICH CONDUCTION OR TRANSMISSION OF IMPULSES OCCURS. ... EFFECTS ON ... CNS, THE AUTONOMIC GANGLIA, THE NEUROMUSCULAR JUNCTION, & ALL FORMS OF MUSCLE. /LOCAL ANESTHETICS/

Biological Half-Life · 3 Einträge

7.7 minutes

SERUM T/2 VALUES FOR PROCAINE WERE LONGER FOR PT WITH LIVER DISEASE (2.3 MIN), PT WITH RENAL FAILURE (1.4 MIN), & NEW-BORN INFANTS (1.4 MIN) THAN FOR HEALTHY ADULTS (0.66 MIN).

INFUSION OF 2% PROCAINE-HCL ADMIN TO 12 WOMEN UNDERGOING HYSTERECTOMY. STEADY-STATE PLASMA LEVELS WERE ACHIEVED WITHIN 20-30 MIN AFTER COMMENCEMENT OF INFUSION. AFTER TERMINATION OF INFUSION DISTRIBUTION T/2 OF 2.49 MIN & ELIMINATION T/2 OF 7.69 MIN.

Metabolism/Metabolites · 5 Einträge

Hydrolysis by plasma esterases to PABA

REDUCED RATE OF PROCAINE HYDROLYSIS IN SERUM FROM UREMIC PT IS DUE TO DECR ENZYME ACTIVITY RATHER THAN COMPETITIVE INHIBITION OF ENDOGENOUS SUBSTANCE IN SERUM.

... /Procaine/ is hydrolyzed in vivo to produce paraaminobenzoic acid ...

YIELDS 2-DIETHYLAMINOETHYL P-ACETAMIDOBENZOATE IN GUINEA PIG; BILLIAR, RB, & EIK-NES, KB, ARCHS BIOCHEM BIOPHYS, 115, 318 (1966). /FROM TABLE/

Hydrolysis by plasma esterases to PABA Route of Elimination: With normal kidney function, the drug is excreted rapidly by tubular excretion. Half Life: 7.7 minutes

MeSH Pharmacological Classification · 1 Eintrag

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Verwendung und Herstellung

Uses · 4 Einträge

Used as a local anesthetic; [Kanerva, p. 1829]

MEDICATION

Use (kg; approx.) in Germany (2009): >750

It is used primarily to reduce the pain of intramuscular injection of penicillin, and it is also used in dentistry. [Wikipedia]

Methods of Manufacturing · 4 Einträge

USUALLY PREPD BY INTERACTION OF 2-DIETHYLAMINOETHANOL WITH P-NITROBENZOYL CHLORIDE, FOLLOWED BY REDUCTION OF 2-DIETHYLAMINOETHYL P-NITROBENZOATE, OR BY ESTERIFYING P-AMINOBENZOIC ACID WITH 2-DIETHYLAMINOETHANOL USING H2SO4 AS CATALYST: US PATENT 812,554 (1906).

Prepn: A. Einhorn, U.S pat 812,554 (1906); Idem, Ann. 371, 125 (1909); A. Einhorn, E. Uhlfelder, ibid. 131.

(1) By heating chloroethyl-p-nitrobenzoic ester with diethylamine for 24 hours under pressure at 120 °C. The product is then reduced with tin and hydrochloric acid. (2) By condensation of ethylene chlorohydrin with diethylamine. The chloroethyldiethylamine formed is heated with sodium-p-aminobenzoate. /Hydrochloride/

Prepared by reacting benzocaine and 2-diethylaminoethanol in the presence of catalytic amounts of sodium and simultaneous removal of the nascent ethanol by distillation. /Hydrochloride/

Formulations/Preparations · 3 Einträge

IT IS AVAIL AS OFFICIAL INJECTION. MARKET PREPN INCL FOLLOWING: AMPULS OR VIALS OF 0.5, 1, 2, OR 10% SOLN WITHOUT EPINEPHRINE, OR 1 OR 2% SOLN WITH EPINEPHRINE IN CONCN OF 1:50,000-1:100,000, FOR INFILTRATION & NERVE BLOCK; 5-20% SOLN IN AMPULS, FOR SPINAL ANESTHESIA ... /HYDROCHLORIDE/

... AMPULS OF STERILE PROCAINE HYDROCHLORIDE CRYSTALS (50-500 MG), FOR SPINAL ANESTHESIA; 0.1 OR 0.2% PROCAINE HYDROCHLORIDE IN ISOTONIC SODIUM CHLORIDE SOLN, FOR IV INFUSION. /HYDROCHLORIDE/

Grade: USP /Hydrochloride/

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing Information · 3 Einträge

INCOMPATIBILITIES: ALKALOIDAL PRECIPITANTS...INCL SOLN OF IODINE & MERCURIC CHLORIDE, CAUSE PRECIPITATION & ALKALIES LIBERATE INSOL PROCAINE BASE. /HYDROCHLORIDE/

Particularly useful with silver nitrate because no percipitate forms /nitrate/

AS A GENERAL RULE, SMALL NERVE FIBERS ARE MORE SUSCEPTIBLE TO THE ACTION OF LOCAL ANESTHETICS THAN ARE LARGE FIBERS. ... SENSATION OF PAIN USUALLY IS THE FIRST MODALITY TO DISAPPEAR ... /LOCAL ANESTHETICS/

Anwendungen

BeschreibungProcaine is a local anesthetic with a para-amino function. Sensitization mainly concerns medical, dental and veterinary professions.

VerwendenProcaine (Novocain) is mainly used in dental or medical procedures requiring infiltration anesthesia, peripheral block, or spinal block.

Anbieter100 Anbieter

北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
Hong Kong Tiansheng New Material Trading Co., Ltd+8617320695765 · [email protected]
Hebei shuoxi biotechnology co. LTD+8613081092107
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI:Procaine is a benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol. It has a role as a local anaesthetic, a central nervous system depressant, a peripheral nervous system drug and a drug allergen. It is a benzoate ester, a substituted aniline and a tertiary amino compound. It is functionally related to a 2-diethylaminoethanol and a 4-aminobenzoic acid. It is a conjugate base of a procaine(1+).

Zugehörige Reaktionen

4

Notizen zur Verbindung

Wird geladen…